Status:
UNKNOWN
Shnaghai Shengkang Medical Center
Lead Sponsor:
Guoxiang Fu
Conditions:
Vascular Diseases
Eligibility:
All Genders
18-85 years
Brief Summary
The process of population aging that is occurring in developed societies represents a major challenge for the health system. The aim of this study is to analyze factors that have an influence on early...
Eligibility Criteria
Inclusion
- • Patients aged 35 to 85 years who agree to participate in the study and do not meet any of the exclusion criteria.
Exclusion
- • Subjects who are in terminal condition, who cannot travel to the health centers to undergo the corresponding examinations, and those who do not wish to sign the informed consent.
- Subjects with a history of CVD (ischemic heart disease or stroke, peripheral arterial disease or heart failure), diagnosed renal failure in terminal stages (glomerular filtration rate below 30%), chronic inflammatory disease, or acute inflammatory process in the past three months.
- Patients treated with estrogens, testosterone, or growth hormone.
Key Trial Info
Start Date :
February 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT03334474
Start Date
February 1 2018
End Date
May 1 2021
Last Update
November 7 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.